Skip to main content
Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Ovarian Cancer
0
0.63
Triple Negative Breast Cancer
0
0.56
HER2-Negative Breast Cancer
0
0.54
Adjuvant Chemotherapy
0
0.53
Chemotherapy
0
0.52
Breast
0
0.45
Cancer
0
0.45
Genomic Medicine
0
0.42
Toxicology
0
0.39
Receptors
0
0.3
Neoadjuvant Therapy
0
0.26
Specialty
Lead
score
Hematology-Oncology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Ob/Gyn & Women's Health
0
1
Pharmacist
0
1
Diabetes & Endocrinology
0
0.89
Public Health & Prevention
0
0.84
Nursing
0
0.51
Infectious Diseases
0
0.49
Emergency Medicine
0
0.4